Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings Data that will inform serologic testing guidance is rapidly evolving.
Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.
Serologic methods have been developed and will have important public health and clinical uses to monitor and respond to the COVID-19 pandemic.
Serologic assays for SARS-CoV-2, now broadly available, can play an important role in understanding the virus’s epidemiology in the general population and identifying groups at higher risk for infection.